Hostname: page-component-848d4c4894-89wxm Total loading time: 0 Render date: 2024-07-07T21:46:49.992Z Has data issue: false hasContentIssue false
  • English
  • Français

Desmielinización del SNC en gammapatía monoclonal de significado desconocido (MGUS): posible causa de un síndrome de demencia

Published online by Cambridge University Press:  12 May 2020

H. Hampel ,
C. Schneider ,
C. Hock ,
F. Müller-Spahn  and
M. Ackenheil
H. Hampel
Affiliation:
Institutos Nacionales de Salud, Instituto Nacional sobre Envejecimiento, Laboratorio de Neurociencias, Bethesda, EE UU
C. Schneider
Affiliation:
Hospital Psiquiátrico, Universidad Ludwig-Maximilian, MunichAlemania
C. Hock
Affiliation:
Hospital Psiquiátrico, Universidad de Basilea, BasileaSuiza
F. Müller-Spahn
Affiliation:
Hospital Psiquiátrico, Universidad de Basilea, BasileaSuiza
M. Ackenheil
Affiliation:
Hospital Psiquiátrico, Universidad Ludwig-Maximilian, MunichAlemania
Get access

Resumen

Sólo algunas publicaciones señalan la posibilidad de participación simultánea del SNC en la enfermedad desmielinizante periférica adquirida. Describimos a dos pacientes con polineuropatía crónica y gammapatía monoclonal de significado desconocido (MGUS) que desarrollaron un síndrome de demencia progresiva con alteraciones extensas de la sustancia blanca cerebral.

Keywords

demenciapolineuropatías crónicasgammapatía monoclonal de significado desconocido (MGUS)enfermedad desmielinizantelesiones de la sustancia blanca (WMLs)autoanticuerpos del SNC
Type
Comunicación breve
Information
European Psychiatry (Ed. Española) , Volume 3 , Issue 4 , August 1996 , pp. 262 - 267
Copyright
Copyright © European Psychiatric Association 1996

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

BIBLIOGRAFIA

Albers, JWKelly, JJ. Acquired inflammatory demyelinating polyneuropathies: clinical and electrodiagnostic features. Muscle Nerve 1989; 12: 435–51.CrossRefGoogle ScholarPubMed
Baig, SYu-Ping, JOlsson, T. Cells secreting anti-MAG antibody occur in cerebrospinal fluid and bone marrow in patients with polyneuropathy associated with M component. B rain 1991; 114: 573–83.Google ScholarPubMed
Bleasel, AFHawke, SHBPollard, JDMcLeod, JG. IgG monoclinical paraproteinaemia and peripheral neuropathy. J Neurol Neurosurg Psychiatry 1993; 56: 52–7.CrossRefGoogle ScholarPubMed
Hachinsky, VCPotter, PMerskey, H. Leuko-Ariosis. A rch Neurol 1987; 44: 21–3.CrossRefGoogle Scholar
Hunt, AlOrrison, WWYeo, RAet al. Clinical significance of white matter lesions in the elderly. Neurology 1989; 39: 1470–4.CrossRefGoogle ScholarPubMed
Jauberteau, MOYounes-Chennoufi, BRigaud, MBaumann, N. IgM gammopathy and polyneuropathy react with an antigenic glycolipid present in human central nervous system. Neurosci Lett 1989; 97: 181–4.CrossRefGoogle ScholarPubMed
Leger, JMYounes, Chennoufi, Bet al. Frequency of central lesions in polyneuropathy associated with IgM monoclonal gammopathy: an MRI, neurophysiological and immunochemical study. J Neurol Neurosurg Psychiatry 1992; 55: 112–15.CrossRefGoogle ScholarPubMed
Mendell, JRKolkin, SKissel, JTWeiss, KLChakers, DWRammohan, KW. Evidence for central nervous system demyelination in chronic inflammatory demyelinating polyradiculoneuropathy. Neurology 1987; 37: 1291–4.CrossRefGoogle ScholarPubMed
Mendell, JRSahenk, ZWhitaker, JNPittman, G. Monoclinal IgM and peripheral neuropathy: studies on passive transfer and antibody characterization. Neurology 1982; 32: A183.Google Scholar
Neundörfer, BBischoff, A. Paraproteinamie. In: Hopf, HPoeck, Schlack, H, ed. Neurologie in Praxis und K linik 3. Stuttgart, New York: Thieme-Verlag, 1993; 4-48.Google Scholar
Poeck, K. Das Problemder Demenz aus der Sicht der Neurologie. Akt Neurol 1988; 15: 1–5.CrossRefGoogle Scholar
Provinciali, LDi-Bella, PLogullo, FVesprini, LPasquine, UScarpelli, M. Evidence of central nervous system involvement in chronic demyelinating neuropathies associated with “benign” gammopathies. R iv Neurol 1989; 59: 36–44.Google ScholarPubMed
Steingart, AHachisnski, VCLau, Cet al. Cognitive and neurologie findings in demented patients with diffuse white matter lucencies on computed tomographic sean (leuko-ariosis). A rch Neurol 1987; 44: 36–9.CrossRefGoogle Scholar
Sudha, RGMohammed, HNYoung, JCGhobrial, MRubino, FAHindo, W. Periventricular white matter changes and dementia: Clinical, neuropsychological, radiological, and pathological correlation. Arch Neurol 1988;45:637-41.Google Scholar
Wahlund, LOAndersson-Lundman, GJulin, PNördstrom, MViitanen, MSääf, J. Quantitative estimation of brain white matter abnormalities in elderly subjeets using magnetic resonance imaging. Magn Reson Imaging 1992; 10: 859–6.CrossRefGoogle ScholarPubMed